Andreas Laustsen-Kiel

Andreas Laustsen-Kiel has a diverse and extensive work experience. Andreas currently serves as a Professor at DTU - Technical University of Denmark, a position they have held since October 2021. Prior to this, they worked as an Associate Professor at DTU from January 2018 to October 2021, and as a Postdoctoral Fellow from June 2016 to January 2018.

In addition to their work at DTU, Laustsen-Kiel has held various roles in different organizations. Andreas served as a Fellow at the Young Academy of Europe starting from June 2020. Andreas was also a Fellow at Det Unge Akademi from September 2019. Moreover, they are the Co-Founder of VenomAid Diagnostics, a company focused on snake venom diagnostics for snakebite envenomings.

Laustsen-Kiel has been involved in several other ventures as well. Andreas served as the Co-Founder and CTO of Bactolife since August 2017. Andreas also co-founded Chromologics in July 2016, Antag Therapeutics in February 2017, VenomAb IVS in January 2013, and Biosyntia in January 2012. At Biosyntia, their role involved business planning and commercialization of novel discovery technology for biocatalysts.

Furthermore, Laustsen-Kiel has contributed their expertise to the World Health Organization, where they served as an Advisor in the WHO Working Group on Snakebite Envenoming. In this role, they were involved in developing a strategic plan to assess and address the global burden of snakebite envenoming.

Overall, Andreas Laustsen-Kiel's work experience spans various academic, entrepreneurial, and advisory roles, emphasizing their expertise in fields such as venom diagnostics, biotechnology, and global health.

Andreas Laustsen-Kiel has a diverse education history. Andreas began their academic journey at the University of Cambridge in 2006, where they obtained a Certificate of Proficiency in English. Following this, they attended the Technical University of Denmark (DTU) from 2007 to 2010 and earned a Bachelor of Science degree in Human Life Science Engineering.

In 2010, Andreas pursued further studies at DTU and was accepted into the Honors Program for the Master of Science in Engineering degree. Andreas successfully completed their honors program in Advanced and Applied Chemistry in 2012. During the same period, they also attended Pierre and Marie Curie University, where they obtained a Master of Science degree in Molecular Chemistry in 2012.

Seeking to explore entrepreneurship in the food and healthcare industry, Andreas attended the University of California, Davis in 2012 for a brief period. Although they did not obtain a specific degree from this institution, they gained valuable knowledge in the field.

In 2014, Andreas embarked on a Ph.D. program at the University of Copenhagen. Andreas specialized in Molecular and Cellular Pharmacology and completed their Doctor of Philosophy (PhD) degree in 2016. Throughout their education, Andreas has consistently demonstrated a diverse range of interests and a commitment to furthering their expertise in various scientific and business disciplines.